Moderna MRNA Grant revenue — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Moderna’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Moderna's grant revenue — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Moderna's grant revenue — total revenue?
- Moderna (MRNA) reported grant revenue — total revenue of $0 in Q1 2026.
- How has Moderna's grant revenue — total revenue changed year-over-year?
- Moderna's grant revenue — total revenue decreased by 100.0% year-over-year, from $1M to $0.
- What is the long-term trend for Moderna's grant revenue — total revenue?
- Over 3 years (2021 to 2025), Moderna's grant revenue — total revenue has grown at a -69.0% compound annual growth rate (CAGR), from $735M to $22M.
- What does grant revenue — total revenue mean?
- This represents the total recognized revenue derived from government or private research grants within a specific business segment. It reflects the financial support received for research and development activities that do not constitute standard commercial product sales. This metric is critical for assessing the company's ability to secure non-dilutive funding for its pipeline development.